Impact of a Triage Liaison Physician

NCT ID: NCT02980159

Last Updated: 2017-07-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

69893 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-11-30

Study Completion Date

2017-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Due to an increasing number of patients admitted in emergency departments, many patients cannot be evaluated immediately after their admission. The function of "triage liaison physician" was introduced in Spring 2015. The objective of this study is to evaluate the impact of this new function on patients' flow in the ED.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Geneva University Hospitals (GUH) emergency department (ED) admits more than 64000 patients every year. These patients are triaged using the Swiss Emergency Triage Scale (SETS), a 4-level triage scale. The SETS imposes time objectives until the first medical evaluation (20 minutes for SETS 2, 2 hours for SETS 3). In 2014, only 60% of level-2 and 63% of level-3 emergencies were evaluated within 20 and 120 minutes respectively.

A triage liaison physician was introduced in Spring 2015 with the mission to help triage nurse in their decisions and to evaluate quickly the patients that cannot be immediately installed in an ED evaluation room.

The objective of this study is to evaluate the impact of the triage liaison physician on the times to first medical evaluation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Emergencies Triage

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Before triage liaison physician

All patients admitted before the introduction of the function of triage liaison physician.

No interventions assigned to this group

After triage liaison physician

All patients admitted after the introduction of the function of triage liaison physician.

Triage liaison physician

Intervention Type OTHER

A triage liaison physician is present from 7:30 am to 10:30 pm, Monday to Friday, with the mission to evaluate quickly patients who cannot be immediately installed in an ED room

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Triage liaison physician

A triage liaison physician is present from 7:30 am to 10:30 pm, Monday to Friday, with the mission to evaluate quickly patients who cannot be immediately installed in an ED room

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* \>= 16 y
* admitted in GUH ED

Exclusion Criteria

* patients triaged to outpatient clinics
Minimum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Geneva

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Olivier T. Rutschmann

Professor, Chief deputy

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Olivier T Rutschmann, MD, MPH

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Geneva

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Geneva University Hospitals, ED

Geneva, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CCER 2016-00179

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.